125 related articles for article (PubMed ID: 34109709)
1. Ovarian clear cell carcinoma with an immature teratoma component showing ARID1A deficiency and an identical PIK3CA mutation.
Kihara A; Iizuka T; Endo S; Horie K; Kanda H; Niki T
J Obstet Gynaecol Res; 2021 Sep; 47(9):3401-3407. PubMed ID: 34109709
[TBL] [Abstract][Full Text] [Related]
2. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma.
Su YF; Tsai EM; Chen CC; Wu CC; Er TK
Clin Chim Acta; 2019 Jul; 494():1-7. PubMed ID: 30851247
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Takano M; Tamai S; Matsubara O
Virchows Arch; 2012 Jan; 460(1):77-87. PubMed ID: 22120431
[TBL] [Abstract][Full Text] [Related]
4. Mixed angiosarcoma, clear cell adenocarcinoma and mature teratoma elements in an ovarian tumor: a case report and literature review.
Takahashi H; Chaopotong P; Kajita S; Hashimura M; Yamazaki H; Saegusa M
Pathol Int; 2012 Aug; 62(8):538-42. PubMed ID: 22827762
[TBL] [Abstract][Full Text] [Related]
5. Loss of HDAC-Mediated Repression and Gain of NF-κB Activation Underlie Cytokine Induction in ARID1A- and PIK3CA-Mutation-Driven Ovarian Cancer.
Kim M; Lu F; Zhang Y
Cell Rep; 2016 Sep; 17(1):275-288. PubMed ID: 27681437
[TBL] [Abstract][Full Text] [Related]
6. Cerebellar Metastasis From Ovarian Carcinoma Harboring PIK3CA-Activating Mutation: A "Clear" Explanation for Unexpected "Vertigo".
Piermattei A; Santoro A; Angelico G; Inzani F; Valente M; Pettinato A; Vatrano S; Scambia G; Fraggetta F; Zannoni GF
Int J Gynecol Pathol; 2020 Jan; 39(1):68-71. PubMed ID: 30252727
[TBL] [Abstract][Full Text] [Related]
7. A case of ovarian clear cell carcinoma arising from ovarian mature cystic teratoma.
Maeda K; Terai Y; Terada S; Maruoka H; Kogata Y; Ashihara K; Tanaka Y; Tanaka T; Sasaki H; Tsunetoh S; Yamada T; Ohmichi M
J Ovarian Res; 2018 Aug; 11(1):74. PubMed ID: 30165878
[TBL] [Abstract][Full Text] [Related]
8. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
[TBL] [Abstract][Full Text] [Related]
9. Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1).
Jiang W; Ye S; Xiang L; Yang W; He T; Pei X; Guo L; Yang H
J Ovarian Res; 2018 Jul; 11(1):58. PubMed ID: 29986747
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Clear Cell Carcinoma and Mature Cystic Teratoma Transformed to PNET and Carcinosarcoma: A Case Report with an Immunohistochemical Investigation.
Matsuo M; Saigo C; Takeuchi T; Onogi A; Watanabe N; Aikyo S; Toyoki H; Yanai H; Tanaka T
Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327349
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
Ye S; Yang J; You Y; Cao D; Huang H; Wu M; Chen J; Lang J; Shen K
Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
[TBL] [Abstract][Full Text] [Related]
12. Precision medicine for ovarian clear cell carcinoma based on gene alterations.
Kuroda T; Kohno T
Int J Clin Oncol; 2020 Mar; 25(3):419-424. PubMed ID: 32020380
[TBL] [Abstract][Full Text] [Related]
13. Growing Teratoma Syndrome Secondary to Ovarian Giant Immature Teratoma in an Adolescent Girl: A Case Report and Literature Review.
Li S; Liu Z; Dong C; Long F; Liu Q; Sun D; Gao Z; Wang L
Medicine (Baltimore); 2016 Feb; 95(7):e2647. PubMed ID: 26886604
[TBL] [Abstract][Full Text] [Related]
14. Immature teratoma of the ovary with distant metastases: favorable prognosis and insights into chemotherapeutic retroconversion.
Kurata A; Hirano K; Nagane M; Fujioka Y
Int J Gynecol Pathol; 2010 Sep; 29(5):438-44. PubMed ID: 20736769
[TBL] [Abstract][Full Text] [Related]
15. Recurrent immature teratoma of the ovary with long-term disease-free interval.
Matsumoto H; Mizoguchi C; Nishida M; Sato S; Nasu K; Narahara H
J Obstet Gynaecol Res; 2014 May; 40(5):1455-8. PubMed ID: 24750519
[TBL] [Abstract][Full Text] [Related]
16. Recurrent High-grade Ovarian Immature Teratoma with Peritoneal Dissemination.
Brind'Amour A; De Guerke L; Fortin S; Gervais MK; Dubé P; Sidéris L
J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):586-589. PubMed ID: 32535217
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of an immature ovarian teratoma with gliomatosis peritonei and recurrence suggests genetic independence of multiple tumors.
Best DH; Butz GM; Moller K; Coleman WB; Thomas DB
Int J Oncol; 2004 Jul; 25(1):17-25. PubMed ID: 15201985
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Kato N; Sato Y; Kamataki A; Fukase M; Uchigasaki S; Kurose A
Hum Pathol; 2019 Apr; 86():32-37. PubMed ID: 30496799
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic excisional surgery for growing teratoma syndrome of the ovary: case report and literature review.
Shigeta N; Kobayashi E; Sawada K; Ueda Y; Yoshino K; Hori Y; Kimura T
J Minim Invasive Gynecol; 2015; 22(4):668-74. PubMed ID: 25620216
[TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
